Patent · US Active

Bone graft substitute composition

US8968465B2 · kind B2 · utility

0Cited by

100References

20Claims

0Family size

Assignee

WRIGHT MEDICAL TECHNOLOGY, INC. · US

Inventors

Jantzen Cole · Memphis, US
Timothy Smith · Cambridge, US

Key dates

Filing date	Jan 16, 2014
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Jan 16, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition includes calcium sulfate hemihydrate, stearic acid, an accelerant, and a mixing solution. The composition can be injected, e.g., through a needle, and is capable of setting, e.g., in vivo, in a relatively short period of time to a relatively high hardness.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.